AIToday
Large Language ModelsAI in HealthcareAI WeeklyPublished: Nov 21, 2026, 13:00 JST

MedChemBench: GPT-6.2 Astra hits 84.5%, OpenAI flags limits

Send on LINE
MedChemBench: GPT-6.2 Astra hits 84.5%, OpenAI flags limits

3 Key Points

  1. What happened

    On OpenAI's MedChemBench, 99 problems drawn from 117 papers and patents covering 761 molecular structures, GPT-6.2 Astra scored 84.5% at the xhigh reasoning setting, ahead of GPT-6 Astra at 83.3% and GPT-6.1 Sol at 82.0%.

  2. Why it matters

    OpenAI states the results do not establish whether models can discover new drugs or improve laboratory decisions, and that prior exposure to the published sources cannot be ruled out—so the ranking is diagnostic, not proof of drug-discovery readiness.

WHO IT HITSPharmaceutical research teams and cheminformatics groups evaluating AI for compound prioritization should treat the MedChemBench ranking as a diagnostic of model weaknesses, not as evidence of lab readiness, given OpenAI's own caveats.

Not sure about something? Ask the AI

Questions and answers are published on this page.

Summaries like this, every morning.

Context & Analysis

MedChemBench is OpenAI's own benchmark, and the company published it alongside explicit caveats. The post states that prior exposure to the 117 source papers and patents cannot be ruled out, and that each response was a single attempt without tools, feedback, or new experiments. That framing positions the 84.5% headline as a diagnostic rather than a readiness certificate.

The full model hierarchy runs from GPT-6.2 Astra at 84.5% to GPT-6 Astra at 83.3%, GPT-6.1 Sol at 82.0%, and GPT-5.6 Sol at 58.2%. Coverage notes that no competing models are scored yet, so the spread describes OpenAI's own progression rather than an industry comparison.

FAQ
What is the difference between GPT-6.2 Astra and GPT-6 Astra on MedChemBench?
GPT-6.2 Astra scored 84.5% of available credit at the xhigh reasoning setting, while GPT-6 Astra scored 83.3%.
Why is the 84.5% score not proof of drug-discovery ability?
OpenAI's post states the results do not establish whether models can discover new drugs or improve laboratory decisions, and that prior exposure to the published sources cannot be ruled out.
Are competing models included in the MedChemBench leaderboard?
No, competing models are not yet scored, limiting external calibration.
Send on LINE

AI news that matters for your work, delivered every morning.

Pick your industry and the AI tools you use, and get news related to your work every day.

Free · 30 seconds with Google · unsubscribe anytimeWhat is AIToday? →

Ask AI

Ask AI anything about this article. The AI reads this article, earlier AIToday articles, and Wikipedia, and cites its sources. Q&As are published on this page for other readers too.

Questions and answers are published on this page.

Related Articles

Next articleAWS Quick adds chat-built flows and Meta ads, Amplitude connectors